Literature DB >> 22694017

Central-airway necrosis after stereotactic body-radiation therapy.

Michael N Corradetti, Andrew R Haas, Ramesh Rengan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22694017     DOI： 10.1056/NEJMc1203770

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  46 in total

1.  Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?

Authors:  Ursula Nestle; José Belderbos
Journal:  Transl Lung Cancer Res       Date:  2015-10

2.  Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?

Authors:  Katrina Woodford; Sashendra Senthi
Journal:  Transl Lung Cancer Res       Date:  2015-10

3.  Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.

Authors:  Amode R Tembhekar; Cari L Wright; Megan E Daly
Journal:  Clin Lung Cancer       Date:  2016-12-22       Impact factor: 4.785

4.  LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.

Authors:  S Adebahr; S Collette; E Shash; M Lambrecht; C Le Pechoux; C Faivre-Finn; D De Ruysscher; H Peulen; J Belderbos; R Dziadziuszko; C Fink; M Guckenberger; C Hurkmans; U Nestle
Journal:  Br J Radiol       Date:  2015-04-15       Impact factor: 3.039

5.  Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.

Authors:  Daniel H Schanne; Ursula Nestle; Michael Allgäuer; Nicolaus Andratschke; Steffen Appold; Ute Dieckmann; Iris Ernst; Ute Ganswindt; Anca L Grosu; Richard Holy; Michael Molls; Meinhard Nevinny-Stickel; Sabine Semrau; Florian Sterzing; Andrea Wittig; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-08-27       Impact factor: 3.621

6.  Malignant tracheal necrosis and fistula formation following palliative chemoradiotherapy: a case report.

Authors:  In Ae Kim; Hyeon Kang Koh; Sun Jong Kim; Kwang Ha Yoo; Kye Young Lee; Hee Joung Kim
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

7.  Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer.

Authors:  Nikhil Sebastian; Trudy Wu; Erin Driscoll; Henning Willers; Suzanne Kelly; Hima Bindu Musunuru; Xiaokui Mo; Yubo Tan; Jose Bazan; Karl Haglund; Meng Xu-Welliver; Andrew M Baschnagel; Andrew Ju; Florence Keane; Terence M Williams
Journal:  Radiother Oncol       Date:  2019-06-05       Impact factor: 6.280

Review 8.  Specific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review.

Authors:  Feras Oskan; Gerd Becker; Martin Bleif
Journal:  Strahlenther Onkol       Date:  2016-11-03       Impact factor: 3.621

9.  Simultaneous integrated protection : A new concept for high-precision radiation therapy.

Authors:  Thomas B Brunner; Ursula Nestle; Sonja Adebahr; Eleni Gkika; Rolf Wiehle; Dimos Baltas; Anca-Ligia Grosu
Journal:  Strahlenther Onkol       Date:  2016-10-18       Impact factor: 3.621

10.  Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree.

Authors:  Justin M Haseltine; Andreas Rimner; Daphna Y Gelblum; Ankit Modh; Kenneth E Rosenzweig; Andrew Jackson; Ellen D Yorke; Abraham J Wu
Journal:  Pract Radiat Oncol       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.